Preferred Label : Spastic paraplegia 35, autosomal recessive, with or without neurodegeneration;
Symbol : SPG35;
CISMeF acronym : FAHN; SPG35;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Fatty acid hydroxylase-associated neurodegeneration; Leukodystrophy, dysmyelinating, and spastic paraparesis with or without dystonia; FAHN;
Description : Autosomal recessive spastic paraplegia-35 is a complicated form of SPG characterized
by childhood onset of gait difficulties due to progressive spastic paraparesis, dysarthria,
and mild cognitive decline associated with leukodystrophy on brain imaging. Other
variable neurologic features, such as dystonia, optic atrophy, and seizures may also
occur (summary by Dick et al., 2010). In addition, some patients with mutations in
the FA2H gene have radiographic evidence of neurodegeneration with brain iron accumulation
(NBIA), thus expanding the phenotype. Kruer et al. (2010) referred to this phenotypic
spectrum of disorders as fatty acid hydrolase-associated neurodegeneration (FAHN).
For a discussion of genetic heterogeneity of autosomal recessive spastic paraplegia,
see SPG5A (270800).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the fatty acid 2-hydroxylase gene (FA2H, 611026.0001);
Prefixed ID : #612319;
Origin ID : 612319;
UMLS CUI : C3496228;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)